These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36117362)

  • 1. [Progress in research of influenza vaccine and 23 valent pneumococcal polysaccharide vaccine immunization in patients with chronic obstructive pulmonary disease].
    Sui HT; Guo Y; Yang ZN; Su JF; Shu X; Zhang Y; Wang HQ; Yang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Sep; 43(9):1508-1512. PubMed ID: 36117362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations.
    Li Y; Zhang P; An Z; Yue C; Wang Y; Liu Y; Yuan X; Ma Y; Li K; Yin Z; Wang L; Wang H
    Respirology; 2022 Oct; 27(10):844-853. PubMed ID: 35705329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
    Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    Song JY; Noh JY; Lee JS; Wie SH; Kim YK; Lee J; Jeong HW; Kim SW; Lee SH; Park KH; Choi WS; Cheong HJ; Kim WJ
    PLoS One; 2018; 13(12):e0207918. PubMed ID: 30521553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease].
    Ignatova GL; Antonov VN
    Ter Arkh; 2022 Dec; 94(11):1257-1261. PubMed ID: 37167163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].
    Matsuse H
    Nihon Rinsho; 2016 May; 74(5):839-42. PubMed ID: 27254956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status.
    Varkey JB; Varkey AB; Varkey B
    Curr Opin Pulm Med; 2009 Mar; 15(2):90-9. PubMed ID: 19532022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health economic evaluation of a 23 value pneumococcal polysaccharide vaccination pilot programme among elderly chronic obstructive pulmonary disease patients in China].
    Qiu YP; Zhao K; Li X; Shi LW; Guo WD; Qi XR; Sui BY; Zhou RM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1074-1078. PubMed ID: 28057111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the effectiveness and long-term results of formation of adaptive immunity in the use of various medications and vaccination schemes against pneumococcal infection in patients with chronic obstructive pulmonary disease].
    Protasov AD; Zhestkov AV; Kostinov MP; Shteiner ML; Tezikov YV; Lipatov IS; Yastrebova NE; Kostinova AM; Ryzhov AA; Polishchuk VB
    Ter Arkh; 2017; 89(12. Vyp. 2):165-174. PubMed ID: 29488477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are younger COPD patients adequately vaccinated for influenza and pneumococcus?
    Gogou E; Hatzoglou C; Zarogiannis SG; Siachpazidou D; Gerogianni I; Kotsiou OS; Varsamas C; Gourgoulianis KI
    Respir Med; 2022 Nov; 203():106988. PubMed ID: 36162248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease.
    Saiphoklang N; Phadungwatthanachai J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2102840. PubMed ID: 35943223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which vaccines for COPD patients?].
    Burgel PR
    Rev Prat; 2024 Jan; 74(1):13-15. PubMed ID: 38329244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress of influenza vaccination, pneumococcal vaccination and COVID-19 vaccination among cancer patients].
    Sui HT; Guo Y; Yang ZN; Su JF; Shu X; Zhang Y; Yang XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jan; 57(1):100-106. PubMed ID: 36655265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.
    Gilchrist SA; Nanni A; Levine O
    Am J Public Health; 2012 Apr; 102(4):596-605. PubMed ID: 22397339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza and pneumococcal vaccination coverage and associated factors in patients hospitalized with acute exacerbations of COPD in China: Findings from real-world data.
    He R; Ren X; Huang K; Lei J; Niu H; Li W; Dong F; Li B; Wang Y; Yang T; Wang C
    Chin Med J (Engl); 2024 May; 137(10):1179-1189. PubMed ID: 37488669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization.
    Song JY; Lee JS; Wie SH; Kim HY; Lee J; Seo YB; Jeong HW; Kim SW; Lee SH; Park KH; Noh JY; Choi WS; Cheong HJ; Kim WJ
    Clin Vaccine Immunol; 2015 Feb; 22(2):229-34. PubMed ID: 25540271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal vaccination and chronic respiratory diseases.
    Froes F; Roche N; Blasi F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3457-3468. PubMed ID: 29255353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study.
    Ding H; Huang J; Ngai CH; Sun Q; Kwok KO; Wang HH; Chong M; Wong MC
    Vaccine; 2022 Feb; 40(9):1282-1288. PubMed ID: 35094867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the effectiveness of joint or sequential vaccination with pneumococcal and influenza vaccines in patients with chronic obstructive pulmonary disease].
    Ignatova GL; Antonov VN; Blinova EV
    Ter Arkh; 2019 Aug; 91(8):12-17. PubMed ID: 32598748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.